Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Methodol. Dec 20, 2025; 15(4): 106591
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.106591
Table 2 Histopathology and operation details, n (%)/mean ± SD
Characteristic
Study population n = 10
Tumor type: Adenocarcinoma8 (80)
Tumor type: Mixed neuroendocrine non-neuroendocrine neoplasm1 (10)
Tumor type: Mucoepidermoid carcinoma1 (10)
pT114 (40)
pT21 (10)
pT35 (50)
pN015 (50)
pN13 (30)
pN22 (20)
Tumor regression scoring according to Mandard, 23 (30)
Tumor regression scoring according to Mandard, 34 (40)
Tumor regression scoring according to Mandard, 41 (10)
Tumor regression scoring according to Mandard, 51 (10)
No neoadjuvant treatment1 (10)
Tumor size in millimeters32.7 ± 23.8
Palpable tumor, yes7 (70)
Palpable tumor, no3 (30)
Microscopic distance to proximal tumor resection line, mm37.3 ± 17.9
Macroscopic distance to proximal tumor resection line, mm45.3 ± 17.3
R0 resection10 (100)
R1 resection0 (0)
Barrett’s dysplasia in resected tissue2 (20)
No Barrett’s dysplasia in resected tissue8 (80)